Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.

Wendy Allen

doi:10.2217/14622416.6.6.603

Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.

Wendy Allen

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	603-614
Number of pages	12
Journal	Pharmacogenomics
Volume	6(6)
Issue number	6
DOIs	https://doi.org/10.2217/14622416.6.6.603
Publication status	Published - Sep 2005

ASJC Scopus subject areas

Genetics(clinical)
Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/14622416.6.6.603

Cite this

@article{252f87db94104e5599e762e893f0a224,

title = "Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.",

author = "Wendy Allen",

year = "2005",

month = sep,

doi = "10.2217/14622416.6.6.603",

language = "English",

volume = "6(6)",

pages = "603--614",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Future Medicine Ltd.",

number = "6",

}

TY - JOUR

T1 - Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.

AU - Allen, Wendy

PY - 2005/9

Y1 - 2005/9

UR - http://www.scopus.com/inward/record.url?scp=25144466613&partnerID=8YFLogxK

U2 - 10.2217/14622416.6.6.603

DO - 10.2217/14622416.6.6.603

M3 - Article

C2 - 16143000

VL - 6(6)

SP - 603

EP - 614

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1462-2416

IS - 6

ER -

Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this